ENvue Medical Inc 美国招股说明书（2026年5月28日版）

This prospectus relates to the resale by the selling stockholder named in this prospectus, from time to time, of up to an aggregate of6,000,768 shares (the “Conversion Shares”) of our common stock, par value $0.001 per share (the “common stock”) issuable upon theconversion of an aggregate of 6,254 shares (the “Series H Shares”) of our Series H Convertible Preferred Stock (the “Series HPreferred Stock”), par value $0.0001 per share and stated value $1,000 per share (the “Stated Value”), at a conversion price of $1.0422 The Series H Shares and the Conversion Shares were issued in reliance upon the exemption from the registration requirements inSection 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) and/or Regulation D promulgated thereunder, as Our registration of the shares of common stock covered by this prospectus does not mean that the selling stockholder will offer or sellany of such shares of common stock. The selling stockholder named in this prospectus, or its donees, pledgees, transferees or othersuccessors-in-interest, may resell the shares of common stock covered by this prospectus through public or private transactions atprevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. For additional information on We will not receive any of the proceeds from the sale of common stock by the selling stockholder. Any shares of common stocksubject to resale hereunder will have been issued by us and acquired by the selling stockholder prior to any resale of such shares No underwriter or other person has been engaged to facilitate the sale of the common stock in this offering. We will bear all costs,expenses and fees in connection with the registration of the common stock. The selling stockholder will bear all commissions and Our common stock is traded on the Nasdaq Capital Market (“Nasdaq”) under the symbol “FEED.” On May 27, 2026, the closing saleprice of our common stock on Nasdaq was $0.9193 per share. Investment in our common stock involves risk. See “Risk Factors” contained in this prospectus on page 4, under similarheadings in our annual and periodic reports filed from time to time with the Securities and Exchange Commission, which areincorporated by reference in this prospectus and in any applicable prospectus supplement. You should carefully read this Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesesecurities or passed upon the adequacy or the accuracy of this prospectus. Any representation to the contrary is a criminal The date of this prospectus is May 28, 2026. ABOUT THIS PROSPECTUS This prospectus is part of the registration statement that we filed with the Securities and Exchange Commission (the “SEC”) pursuantto which the selling stockholder named herein may, from time to time, offer and sell or otherwise dispose of the shares of our commonstock covered by this prospectus. As permitted by the rules and regulations of the SEC, the registration statement filed by us includes This prospectus and the documents incorporated by reference into this prospectus include important information about us, thesecurities being offered and other information you should know before investing in our securities. You should not assume that theinformation contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus orthat any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by You should rely only on this prospectus and the information incorporated or deemed to be incorporated by reference in this prospectus.We have not, and the selling stockholder has not, authorized anyone to give any information or to make any representation to you otherthan those contained or incorporated by reference in this prospectus. If anyone provides you with different or inconsistent information, We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to anydocument that is incorporated by reference in this prospectus were made solely for the benefit of the parties to such agreement,including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a Unless otherwise indicated, information contained or incorporated by reference in this prospectus concerning our industry, includingour general expectations and market opportunity, is based on information from our own management estimates and research, as well asfrom industry and general publications and research, surveys and studies conducted by third parties. Management estimates arederived from publicly available information, our knowledge of our industry and assumptions based on such information and PROSPECTUS SUMMARY This summary provides an overview of selected informati